Company intelligence / Profile preview

iSpecimen

Lexington, Massachusetts, United Statesispecimen.com ↗

Ownership: Private
Development stage: Other

Overview

iSpecimen operates an online marketplace that connects researchers with human biospecimens from diverse global sources to accelerate biomedical research. The company does not conduct clinical trials or have therapeutic programs but enables access to annotated samples for discovery and development purposes.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

OneBlood (blood center partnership and investor)

Beyond the preview

Go deeper on iSpecimen.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on iSpecimen.

Explore the full profile